Novozymes A/S (NVZMY) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $60.03. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Financials: revenue is $4.2B, -22.7%/yr average growth. Net income is $584M, growing at -5.6%/yr. Net profit margin is 14% (healthy). Gross margin is 53.9% (-0.7 pp trend).
Balance sheet: total debt is $22.4B against $10.9B equity (Debt-to-Equity (D/E) ratio 2.07, leveraged). Current ratio is 0.72 (tight liquidity). Debt-to-assets is 137.3%. Total assets: $16.3B.
Analyst outlook: 0 / 2 analysts rate NVZMY as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 15/100 (Fail), Past 100/100 (Pass), Health 33/100 (Fail), Moat 76/100 (Pass), Future 20/100 (Fail), Income 55/100 (Partial).